http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100049929-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89e2e7cc11207e6393be4acd229a8ea8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-035 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12 |
| filingDate | 2008-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8f7eaba52a1c51491b3ece539eee194 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab13d5b48e486947839947ebf1c9d7fc |
| publicationDate | 2010-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20100049929-A |
| titleOfInvention | Edema factor modulator and pharmaceutical composition comprising the same |
| abstract | The present invention provides an edema factor modulator comprising the compound of formula 1 and a pharmaceutical composition comprising the same:n n n [Formula 1]n n n n n n n n Wherein R 1 to R 2 are the same as or different from each other, and are each independently selected from the group consisting of hydrogen, alkyl having 1 to 7 carbon atoms, and alkoxy having 1 to 7 carbon atoms, and R 4 to R 7 are the same as or different from each other; Each independently hydrogen or alkyl having 1 to 7 carbon atoms, R and R 'are the same as or different from each other, and each hydrogen or alkyl having 1 to 7 carbon atoms, n is an integer of 1 to 10, and x and y are Each is an integer of 1 to 4, X 1 and X 2 are each independently hydrogen or a hydroxy group and at least one of X 1 and X 2 is a hydroxy group.n n n The edema factor modulator of the present invention can be effectively used for anthrax infection, skin melanin pigmentation, etc. by effectively controlling the amount of edema factor involved in anthrax activity and the like. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015073021-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10669227-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10300000-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11608309-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9675576-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9556105-B2 |
| priorityDate | 2008-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 139.